dihexa potency compared to bdnf synaptogenesis as a Promising Therapeutic Agent in Parkinson's Disease Dimeric mimetic of BDNF loop
Description
As a small molecule weighing approximately 529 Da, orforglipron binds to an allosteric pocket within the transmembrane domain of the GLP-1 receptor, stabilizing the active receptor conformation and driving downstream signaling through Gs protein coupling and cAMP accumulation
IV infusion frequency differs because these sessions deliver a broader nutrient combination
Simpson H, Savine R, Snksen P, Bengtsson B-A, Carlsson L, Christiansen JS, Clemmons D, Cohen P, Hintz R, Ho K, Mullis P, Robinson I, Strasburger C, Tanaka T, Thorner M
The two work through different mechanisms and may produce additive benefits
User 12 used 500mcg daily and was specifically trying to determine whether splitting that dose or taking it all at once produced better results
